LONDON, March 13, 2018 /PRNewswire/ —
Avillion, a drug development company focused on the co-development and financing of pharmaceutical candidates from proof-of-concept through to regulatory approval, has signed a clinical co-development agreement with Pearl Therapeutics Inc., a…
